Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Advancement in endocrine therapy for breast cancer]

[Advancement in endocrine therapy for breast cancer] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Advancement in endocrine therapy for breast cancer] Abstract Text:

    ming-tian yangMing-Tian Yang,zhen-qiang lianZhen-Qiang Lian,

    Endocrine therapy with certain effect is an important part of combined therapy for hormone receptor-positive breast cancer. The endocrine therapy for breast cancer has made progress with the development of new endocrine drugs. Now, tamoxifen is still the standard endocrine therapeutic drug for the premenopausal patients, but aromatase inhibitors can bring more benefit for the postmenopausal patients. Several large-scale clinical trials about aromatase inhibitors and medical ovarian ablation are ongoing and attract attention widely. This review overviewed the endocrine therapy for breast cancer, and mainly introduced its recent advancement.

    [Advancement in endocrine therapy for breast cancer] Publishing Authors By Initials

    mt yangMT Yang,zq lianZQ Lian,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Advancement in endocrine therapy for breast cancer] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Ai zheng = Aizheng = Chinese journal of cancer

    VOLUME: 26

    Page Numbers: 440-4

    Journal Abbreviation:

    ISSN: 1000-467X

    DAY: 13

    MONTH: Apr

    YEAR: 2007

    [Advancement in endocrine therapy for breast cancer] Information

    Number of References:

    LANGUAGE: chi

    NlmUniqueID: 9424852

    [Advancement in endocrine therapy for breast cancer] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Advancement in endocrine therapy for breast cancer] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Advancement in endocrine therapy for breast cancer]

    AFFILIATION: State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China. yangmt@mail.sysu.edu.cn

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ai Zheng

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Advancement in endocrine therapy for breast cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News